Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

Authors

• Mary-Elizabeth Percival, Division of Hematology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. mperciva@seattlecca.org.
• Hai-Lin Wang, CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.Follow
• Mei-Jie Zhang, CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.Follow
• Wael Saber, CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
• Marcos de Lima, Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
• Mark Litzow, Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN, USA.
• Partow Kebriaei, Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
• Hisham Abdel-Azim, Division of Hematology, Oncology and Blood & Marrow Transplantation, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
• Kehinde Adekola, Division of Hematology and Oncology, Department of Medicine and Robert H. Lurie Comprehensive Cancer, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
• Mahmoud Aljurf, Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
• Ulrike Bacher, Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
• Sherif M. Badawy, Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.Follow
• Amer Beitinjaneh, University of Miami, Miami, FL, USA.Follow
• Nelli Bejanyan, Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA.Follow
• Vijaya Bhatt, The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA.Follow
• Michael Byrne, Vanderbilt University Medical Center, Nashville, TN, USA.
• Jean-Yves Cahn, Department of Hematology, CHU Grenoble Alpes, Grenoble, France.Follow
• Paul Castillo, UF Health Shands Children's Hospital, Gainesville, FL, USA.Follow
• Nelson Chao, Department of Medicine, Division of Cell Therapy and Hematology, Duke University Medical Center, Durham, NC, USA.Follow
• Saurabh Chhabra, CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.Follow
• Edward Copelan, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.
• Corey Cutler, Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
• Zachariah DeFilipp, Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA, USA.Follow
• Ajoy Dias, Beth Israel Deaconess Medical Center, Westwood, KS, USA.
• Miguel Angel Diaz, Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
• Elihu Estey, Division of Hematology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
• Nosha Farhadfar, Division of Hematology and Oncology, University of Florida College of Medicine, Gainesville, FL, USA.Follow
• Haydar A. Frangoul, The Children's Hospital at TriStar Centennial and Sarah Cannon Research Institute, Nashville, TN, USA.
• César O. Freytes, Texas Transplant Institute, San Antonio, TX, USA.Follow
• Robert Peter Gale, Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.Follow
• Siddhartha Ganguly, Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, KS, USA.Follow
• Lohith Gowda, Yale New Haven Hospital, New Haven, CT, USA.Follow
• Michael Grunwald, Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA.

Publication Title

Bone marrow transplantation

Recommended Citation

Percival, Mary-Elizabeth; Wang, Hai-Lin; Zhang, Mei-Jie; Saber, Wael; de Lima, Marcos; Litzow, Mark; Kebriaei, Partow; Abdel-Azim, Hisham; Adekola, Kehinde; Aljurf, Mahmoud; Bacher, Ulrike; Badawy, Sherif M.; Beitinjaneh, Amer; Bejanyan, Nelli; Bhatt, Vijaya; Byrne, Michael; Cahn, Jean-Yves; Castillo, Paul; Chao, Nelson; Chhabra, Saurabh; Copelan, Edward; Cutler, Corey; DeFilipp, Zachariah; Dias, Ajoy; Diaz, Miguel Angel; Estey, Elihu; Farhadfar, Nosha; Frangoul, Haydar A.; Freytes, César O.; Gale, Robert Peter; Ganguly, Siddhartha; Gowda, Lohith; and Grunwald, Michael, "Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation" (2021). Loewenberg College of Nursing Faculty Publications. 38.
https://digitalcommons.memphis.edu/lcon-facpubs/38